Table 3.
Logistic analysis of clinical factors for ORR (with two cycles of ICI) in 54 HCC patients.
| Clinical Factors | Univariable | P value |
|---|---|---|
| HR (95% CI) | ||
| Sex (Male, Female) | 2.000 (0.362–11.048) | 0.427 |
| Age (< 60 y, ≥ 60 y) | 2.600 (0.801–8.437) | 0.112 |
| ECOG performance status (0-1, 2) | 0.451 (0.123–1.654) | 0.230 |
| HBs–Ag (+, −) | 0.323 (0.049–2.131) | 0.241 |
| AFP (<400 ng/mL, ≥400 ng/mL) | 1.069 (0.349–3.274) | 0.907 |
| Child–Pugh class (A, B) | 0.781 (0.239–2.556) | 0.683 |
| Largest tumor size (< 5 cm, ≥ 5cm) | 1.846 (0.434–7.850) | 0.406 |
| BCLC stage (A, B, C) | 1.810 (0.547–5.992) | 0.331 |
| Liver tumor number (<3, ≥3) | 0.550 (0.171–1.771) | 0.316 |
| Macro vascular invasion (+, −) | 1.444 (0.459–4.537) | 0.530 |
| Extrahepatic metastasis (+, −) | 1.443 (0.458–4.536) | 0.529 |
| cTACE treatment (+, −) | 0.225 (0.062–0.814) | 0.023* |
*p < 0.05.